Randox Signs Principal Partnership with Sheffield United FC

Home - Archives for May 2021

Randox Signs Principal Partnership with Sheffield United FC

COVID-19 Testing        News        Contact Us

26th May 2021 – Randox Signs Principal Partnership with Sheffield United FC 

Global innovative healthcare company and the UK’s largest COVID-19 PCR testing provider Randox is today pleased to announce that it has signed a three-year principle partnership agreement with Sheffield United. The partnership will commence in the 2021 /2022 season and will include both men’s and women’s first team. From next season both teams will wear the Randox logo on their jerseys.

Founded in 1982 in County Antrim by leading medical scientist, Dr. Peter FitzGerald‎ CBE, Randox has been a pioneer in improving health and enhancing lives, worldwide. To achieve their goals the company is committed to an extensive research programme, including  investing more than £300m in the development of its innovative biochip array programme to enable earlier, more accurate diagnosis. The company currently employs more than 2000 people of over 40 different nationalities.

Randox is a world leader in healthcare diagnostics; today more than 5% of the world’s population – in excess of 370 million people across 145 countries – receives medical diagnosis through use of Randox products each year. Over the past year, Randox has been at the forefront of the UK’s fight against COVID-19, and has significantly invested in its testing capacity meaning that it can now process over 500,000 tests per day, making it amongst the very largest COVID-19 laboratories in Europe.  To date Randox having processed over 13 million COVID-19 PCR tests in the UK and now have comprehensive Covid-19 testing, logistics and customer services available to support overseas holidays and those undertaking international travel.

Randox has a proud history of supporting sports, and has been the Official Partner of the, the Grand National since 2017.

Dr. Peter FitzGerald‎ CBE, Randox Chief Executive Officer, said;

“We are very excited about this partnership and the opportunity to align Randox with Sheffield United Football Club. Not only is Sheffield the birthplace of football, but it is also one of the fastest growing cities in developing sports science and medical technology which we are very keen to see how we can look to assist through our services. We are extremely proud to be the principal partner of the Blades and to be a part of the club’s progress in the years to come.”

For press enquiries please contact Amy Millar in the Randox PR team on amy.millar@randox.com or 028 9442 2413

Sheffield United

Want to know more?

Contact us or visit Randox Health.

Related COVID-19 Products and Services

HOME TEST

ANTIBODY TEST

TEST TO RELEASE

LABORATORY TOOLS


Randox supports Northern Ireland travellers to the Algarve with essential COVID-19 PCR ‘test-to-return’ service

COVID-19 Testing        News        Contact Us

21st May 2021 – Randox supports Northern Ireland travellers to the Algarve with essential COVID-19 PCR ‘test-to-return’ service

The NI Executive has today announced that, from 24th May,  travellers from Portugal to Northern Ireland must arrive with a negative COVID-19 PCR test.  This varies from travellers to England, where a lateral flow test is also a possibility.  Randox, the UK’s largest COVID-19 PCR testing provider, have recently announced that travellers to the Algarve will be able to purchase a COVID-19 “test-to-return” kit. In a first for the industry, NI holidaymakers will then be able to have their self-collected samples promptly flown from their holiday destination to Randox’s laboratories in Antrim for gold standard PCR testing. Results are emailed to the traveller ready in time for their flight home.

In response to high demand from British holidaymakers to visit Portugal, Randox has partnered with the largest laboratory chain in the Algarve to offer holidaymakers to the region this new quick and easy solution. Travellers simply purchase and take their ‘test-to-return’ kit to Portugal and, at their convenience, self-collect their sample 3 days before the return flight.  Travellers drop their sample at one of the listed partner laboratory sites and samples are then flown to Randox’s testing facilities in Antrim.  Customers receive their results the next day.  The partner laboratory has many convenient sites across the Algarve, including at Lagos, Portimao, Lagoa, Silves, Albufera, Loule, Faro, Olaho and Quartiera.

The PCR test-to-return service will be available to travellers returning on flights from the Algarve from the 7th June and will cost £60 per testing kit. As a package travellers from NI can also purchase from Randox PCR tests for pre-departure from the UK and the required Day 2 test on return.

Sophie Boyd, Randox Operations Manager, said;

“As the UK gradually opens up to international travel, we are delighted to be able to offer those visiting the Algarve the ability to have a fast and reliable PCR ‘test-to-return’ service, which means travellers have one less thing to worry about and can concentrate on enjoying their holiday. This is particularly relevant for travellers from Northern Ireland. Through our partner network we also have support for the traveller in the Algarve, should they need it.

“Randox is now able to process 500,000 tests a day for international travel – more than any other laboratory in Europe – and to date our laboratories have processed over 13 million tests. We are working hard to support the international fight against the pandemic by offering testing services that allow people to live their lives as normally as possible.

Randox, with almost 40 years of international diagnostics experience, has been at the forefront of COVID-19 testing since the outset of the pandemic. With proven testing capability and well-established logistics and customer support services, Randox are strongly placed to support the return to international travel.

Randox, with almost 40 years of international diagnostics experience, has been at the forefront of COVID-19 testing since the outset of the pandemic. With proven testing capability and well-established logistics and customer support services, Randox are strongly placed to support the return to international travel.

For further information on our COVID testing services please contact the Randox COVID Customer Support team on covidcustomersupport@randox.com or 0800 2545 201.

Want to know more?

Contact us or visit Randox Health.

Related COVID-19 Products and Services

HOME TEST

ANTIBODY TEST

TEST TO RELEASE

LABORATORY TOOLS


Randox and Ulster University – a Winning Team for the Sports Stars of the Future

About Randox       News        Contact Us

Randox and Ulster University – a Winning Team for the Sports Stars of the Future

Ulster University has teamed up with global healthcare company Randox Laboratories Ltd, to extend their major university-wide student sports sponsorship deal for a further three years.

The investment will continue to supply kit and equipment for 70 sports clubs across the university’s four campuses, including individual and team sports such as basketball, GAA, hockey, football, athletics and more. For example, this investment from Randox has helped the University to install world leading performance analysis equipment Spiideo, which allows the University to live stream club games and training sessions, and to give instant pitch side performance analysis and feedback to student players.

Since Randox began sponsoring Ulster University sport in 2018 there have been so many sporting successes at the University:

  • 5000 students have taken part in sports club activities
  • More than 3000 students have worn a Randox jersey
  • 550 Talented Athletes and Performance Sport Scholars have received training and performance kit
  • 7 Ulster University students competed at the last Commonwealth Games (Athletics, Boxing, Rifle Shooting, Swimming)
  • 3 of students are competing at a world level in Judo
  • 6 students are training to qualify for the Tokyo Olympics (Judo and Swimming)
  • Across our 70+ sports clubs there were almost 150 finalist positions in their respective sports- including 89 individuals or teams winning first place
  • The NI Women’s football team that recently qualified for Euro 2022 includes 3 current Ulster University students, 4 graduates and one member of our sports staff

Dr Peter FitzGerald, Randox Managing Director said;

“Randox is passionate about fostering talent and see our university-wide student sports sponsorship as a brilliant opportunity to nurture the young sporting stars of Northern Ireland. We are delighted to extend our partnership with the Ulster University sports teams and look forward to supporting these students as they thrive in both the sporting and academic spheres.”

Professor Paul Bartholomew, Vice-Chancellor at Ulster University added;

“The University enjoys a longstanding, strategic partnership with Randox built upon shared interests in knowledge sharing and talent development. I am delighted that Randox has chosen to continue to partner with us on this very fruitful sports sponsorship to support our talented students as they strive for sporting success and physical and mental wellbeing.”

Karen Delgado, Head of Corporate Engagement, Ulster University commented;

“Strong industry relationships have always been a key part of the Ulster University success story and this fantastic partnership with Randox has been invaluable to our sporting clubs. Their generous support has enriched our campus life, contributed to our excellent student experience, and had an impact across the lives of both the 1,500+ Ulster University Students’ Union Sports Members and our wider student community. Thank you Randox for your continuing support.”

Ben McCarron, player on Ulster University’s GAA team said;

“The partnership with Randox has provided us with a fantastic platform to be successful through coaching, team support and resources. Their support allows all players to train and compete at the top level at University Sport and strive to be the best that we can be.”

For press enquiries please contact Amy Millar in the Randox PR team on amy.millar@randox.com or 028 9442 2413

 

Want to know more?

Contact us or visit Ulster University.

Related Pages

ABOUT RANDOX

NEWS

VACANCIES

OUR PEOPLE


The Importance of Diagnostic Testing in SARS-CoV-2 Adverse Outcomes

SARS-CoV-2 (COVID-19), a highly contagious disease, primarily manifests as an acute respiratory illness, however, for those with health complications, including: autoimmune diseases, asthma, heart disease and diabetes, the risk of developing serious illness and adverse outcomes is much greater. It is estimated that 1 in 6 will experience adverse outcomes that could be life-threatening 1. The spread and devastation of COVID-19 highlights the vital role laboratory diagnostics plays in the diagnosis and management of suspected and affected patients. As the COVID pandemic continues, it is imperative that fast and accurate diagnostic testing strategies are implemented for effective risk stratification and monitoring of treatment and recovery.

In this article, we will review how Randox Reagents can aid in diagnosing and managing SARS-CoV-2 adverse outcomes.

 

Cytokine Storms

The immune system activates a pro-inflammatory response to enhance host immunity against viruses and decrease colonisation and infection, but only if the pro-inflammatory response is controlled. Uncontrolled pro-inflammatory responses can result in a cytokine storm 2. A cytokine storm is a serious complication associated with SARS-CoV-2, which can trigger life-threatening pneumonia, acute respiratory distress syndrome (ARDS) and multiple organ failure 3, 4. Cytokine storms occur in 5% of severe COVID-19 cases, with several inflammatory cytokines observed at high levels. Due to the elevation of several pro-inflammatory and anti-inflammatory cytokines, a multiplex immunoassay approach can offer several advantages over the widely utilised single ELISA tests. The simultaneous detection of multiple cytokines from a single patient sample will provide clinicians with a comprehensive overview of cytokine markers and complete patient profile, facilitating a personalised treatment plan to be implemented 5, 6.

Cytokine Storms Image

Inflammation

In COVID-19 patients, CRP testing has proved to perform well in discriminating disease severity and predicting adverse outcomes 7. Elevated CRP levels have been identified in 86% of patients admitted to hospital. CRP measurements are useful in diagnosis, prognosis and monitoring for clinical improvements or deterioration. Moreover, the acute phase reactant, ferritin, has been observed to increase in approximately 60% of COVID-19 patients. In the critically ill COVID-19 patients, extremely elevated ferritin concentrations were recorded, which could be attributed to a cytokine storm and secondary haemophagocytic lymphohistiocytosis (a hyper-inflammatory syndrome associated with multi-organ failure) 8.

Renal Function

Acute kidney injury (AKI) is a common complication in diabetic patients who test positive for COVID-19. Regardless, the National Institute for Health and Care Excellence (NICE) recommend AKI testing in all COVID-19 patients upon hospital admission and their condition monitored throughout their stay 9.

The most commonly utilised screening test for renal impairment is serum creatinine (SCr); however, it is important to consider the accuracy and reliability of the method. Two commercially available methods exist for SCr determination: Jaffe and enzymatic. Whilst the Jaffe method is less expensive, it is more susceptible to interferences which can lead to the misdiagnosis of patients, which isn’t ideal in the current pandemic 7. Moreover, the sensitivity of SCr, regardless of method, in the early detection of renal disease is poor, as SCr is insensitive to small changes in glomerular filtration rate (GFR). Up to 50% of renal function can potentially be lost before significant SCr levels become detectable 8, 9. In comparison, cystatin C (CysC) is a superior marker of renal function and is useful in the determination of the extent of renal damage, as well as distinguishing those with severe and mild COVID-19 10.

Hepatic Function

Liver Image

Abnormal liver function tests significantly increases a COVID-19 patients risk of developing severe disease and complications such as pneumonia 11. Bilirubin levels, 3 times the upper limit have been observed in COVID-19 patients 11, 12. Whilst the diazo method is commonly utilised in bilirubin testing, superior methods exist. The vanadate oxidation (VO) method offers several advantages particularly in haemolytic and lipemic samples. These advantages are particularly evident in neonatal and infant populations where haemolysis is extremely common. Moreover, the VO method offers a wider analytical measurement range for the comfortable detection of clinically important results 13.

Other liver function markers are known to be elevated in COVID-19 patients including both AST and ALT, with markers like albumin decreased.

The Importance of Lp(a) Testing

Lipoprotein(a) / Lp(a), a strong independent marker of cardiovascular disease risk has recently been identified as a key risk marker of cardiovascular complications in COVID-19 patients. Those with either baseline elevated or elevated levels of Lp(a) following COVID-19 infection may be at a significantly increased risk of developing thromboses. Consideration should be given to measurement of Lp(a) and prophylactic anticoagulation of infected patients to reduce the risk. Elevated Lp(a) levels may also cause acute destabilization of pre-existing but quiescent, atherosclerotic plaques, which could induce an acute myocardial infarction (AMI) or cerebrovascular accident (CVA) (stroke) 14.

The size heterogeneity of apo(a) isoforms represents the biggest challenge faced by laboratories in accurately measuring Lp(a).  The variable numbers of repeated KIV-2 units in act as multiple epitopes, and so standardisation across calibrators is vital. Unless the calibrants have the same range of isoforms as test samples, those with higher numbers of the KIV-2 repeat, will represent with an overestimation in Lp(a) concentrations and those with smaller numbers of the KIV-2 repeat, will represent with an underestimation. The smaller isoforms are strongly associated with higher Lp(a) concentrations 15.

Lp(a) assays that are standardised to the WHO/IFCC (World Health Organization/International Federation of Clinical Chemistry) reference material, transferring values from mg/dl to nmol/l are more uniform. The assay considered the most reliable commercially available Lp(a) assay is so because: 15

1. The isoform size variations are reduced as a range of calibrators from separate pools of serum used, which covered a range of Lp(a) concentrations.

2. The isoform size and concentrations are inversely correlated, better matching calibrants with test samples.

3. Methods are calibrated in nmol/l and traceable to WHO/IFCC reference material and give acceptable bias compared with the Northwest Lipid Metabolism and Diabetes Research Laboratory (NLMDRKL) gold standard method.

Want to know more?

Contact us or visit our COVID-19 disease management webpage.

Related Products

Extended Coronavirus Array

Qnostics SARS-CoV-2 Control

AKI Array


Randox launches new £60 Covid19 ‘test-to-return’ service for travellers to the Algarve

COVID-19 Testing        News        Contact Us

19 May 2021: Randox launches new £60 Covid19 ‘test-to-return’ service for travellers to the Algarve

Randox, the UK’s largest Covid-19 PCR testing provider, announces that from today travellers to the Algarve will be able to purchase a COVID-19 “test-to-return” kit. In a first for the industry, UK holidaymakers will then be able to have their self-collected samples promptly flown from their holiday destination to Randox’s laboratories in the UK for gold standard PCR testing. Results are emailed to the traveller ready in time for their flight home.

In response to high demand from British holidaymakers to visit Portugal, Randox has partnered with the largest laboratory chain in the Algarve to offer holidaymakers to the region this new quick and easy solution.

Travellers simply purchase and take their ‘test-to-return’ kit to Portugal and, at their convenience, self-collect their sample 3 days before the return flight.  Travellers drop their sample at one of the listed partner laboratory sites and samples are then flown to Randox’s testing facilities in the UK.  Customers receive their results the next day.  The partner laboratory has many convenient sites across the Algarve, including at Lagos, Portimao, Lagoa, Silves, Albufera, Loule, Faro, Olaho and Quartiera.

The PCR test-to-return service will be available to travellers returning on flights from the Algarve from the 7th June and will cost £60 per testing kit. This latest offering from Randox removes the stress of holidaymakers trying to find local providers with testing capacity, and adds to the company’s existing traveller focussed services, which include: Pre-Departure (From the UK); Test to Release (Day 5); Day 2 Testing (Green Countries); and Day 2 and Day 8 Testing (Amber countries).

Sophie Boyd, Randox Operations Manager, said;

“As the UK gradually opens up to international travel, we are delighted to be able to offer those visiting the Algarve the ability to have a fast and reliable PCR ‘test-to-return’ service, which means travellers have one less thing to worry about and can concentrate on enjoying their holiday. Through our partner network we also have support for the traveller in the Algarve, should they need it.

“Randox is now able to process 500,000 tests a day for international travel – more than any other laboratory in Europe – and to date our laboratories have processed over 13 million tests. We are working hard to support the international fight against the pandemic by offering testing services that allow people to live their lives as normally as possible.”

Randox, with almost 40 years of international diagnostics experience, has been at the forefront of Covid-19 testing since the outset of the pandemic. With proven testing capability and well-established logistics and customer support services, Randox are strongly placed to support the return to international travel.

 

To book a Test to Return test please click here.

To book a Test to Return travel pack please click here.

For further information on our Covid testing services please contact the Randox Covid Customer Support team on covidcustomersupport@randox.com or 0800 2545 201.

For press enquiries please contact Amy Millar in the Randox PR team on amy.millar@randox.com or 028 9442 2413

 

Want to know more?

Contact us or visit Randox Health.

Related COVID-19 Products and Services

HOME TEST

ANTIBODY TEST

TEST TO RELEASE

LABORATORY TOOLS


15th May 2021: 13 million tests on the National Testing Programme

Randox Logo

   

15TH MAY 2021: THE 13 MILLION MILESTONE 

We are pleased to let you know that on 15th May 2021, Randox processed its 13 millionth sample within the UK COVID-19 National Testing Programme.

That’s an incredible 13 million samples processed by our dedicated and talented staff.

Our staff are our best asset and have risen to the challenge this pandemic has created.

They have worked hard and flexibly, been creative and innovative, and pulled together as a team to make an impact in the fight against COVID-19.

We are very proud of their efforts and teamwork.

Let us once again say thank you to each and every member of Team Randox, for the efforts they have made.

What we do at Randox remains vital to the national and global management of COVID-19 and our work is making a real and positive difference.

We continue to work hard and improve, for the sake of our family, friends and communities.

For further information please email randoxpr@randox.com

Randox in the media

Latest News

FAQs


Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Molecular
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Future Diagnostics
×
Make an Enquiry - RX series (Product)
×
Make an Enquiry - Quality Control
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - RIQAS
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Por favor, introduzca sus datos para ver nuestro último seminario
×
Wyślij zapytanie
  • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje Polityki Prywatności.
×
Wyślij zapytanie